The significant reduction of at list one of the primary outcome endpoints which include levels of fasting plasma glucose, postprandial blood glucose, HbA1c, insulin, insulin resistance and onset of diabetes were demonstrated in all studies. The gene discussed is INS; the disease is diabetes mellitus.